ACAD
ACAD
US0042251084
ACADIA Pharmaceuticals Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
3.39B EUR
4.35B EUR
3.81B EUR
4.55B EUR
Enterprise Value
2.49B EUR
4.04B EUR
3.58B EUR
4.42B EUR
Valuation Multiples
Trailing P/E
8.87x
11.45x
10.14x
12.23x
Forward P/E
22.26x
--
--
--
Price to Sales
2.97x
3.82x
3.48x
5.5x
Price to Book
2.61x
3.33x
3.05x
3.71x
EV/Revenue
2.19x
3.55x
3.27x
5.35x
EV/EBITDA
25.32x
41.1x
38.58x
46.89x
Price to FCF (P/FCF)
49.34x
29.91x
17.93x
24.77x
EV/FCF
36.29x
27.77x
16.84x
24.08x
FCF Yield
2.03%
3.34%
5.58%
4.04%
ende